Gene Expression Profiles of Tumor Biology Provide a Novel Approach to Prognosis and May Guide the Selection of Therapeutic Targets in Multiple MyelomaANGUIANO, Ariel; TUCHMAN, Sascha A; POTTI, Anil et al.Journal of clinical oncology. 2009, Vol 27, Num 25, pp 4197-4203, issn 0732-183X, 7 p.Article

RENAL SHIELDING AND DOSIMETRY FOR PATIENTS WITH SEVERE SYSTEMIC SCLEROSIS RECEIVING IMMUNOABLATION WITH TOTAL BODY IRRADIATION IN THE SCLERODERMA: CYCLOPHOSPHAMIDE OR TRANSPLANTATION TRIALCRACIUNESCU, Oana I; STEFFEY, Beverly A; LONG, Gwynn et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 4, pp 1248-1255, issn 0360-3016, 8 p.Article

International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple MyelomaLOKHORST, Henk; EINSELE, Hermann; GIRALT, Sergio et al.Journal of clinical oncology. 2010, Vol 28, Num 29, pp 4521-4530, issn 0732-183X, 10 p.Article

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaRIZZIERI, David A; SAND, Gregory J; FOSTER, Tracy et al.Cancer. 2004, Vol 100, Num 11, pp 2408-2414, issn 0008-543X, 7 p.Article

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple MyelomaHELD, Lauren A; RIZZIERI, David; LONG, Gwynn D et al.Cancer investigation. 2013, Vol 31, Num 1-10, pp 172-176, issn 0735-7907, 5 p.Article

Partially matched, nonmyeloablative allogeneic transplantation : Clinical outcomes and immune reconstitutionRIZZIERI, David A; LIANG PIU KOH; NIEDZWIECKI, Donna et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 690-697, issn 0732-183X, 8 p.Article

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantationSNYDER, Matthew J; STENZEL, Timothy T; BUCKLEY, Patrick J et al.The American journal of surgical pathology. 2004, Vol 28, Num 6, pp 794-800, issn 0147-5185, 7 p.Article

Phase 1 trial study of ¹³¹I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphomaRIZZIERI, David A; AKABANI, Gamal; PEGRAM, Charles N et al.Blood. 2004, Vol 104, Num 3, pp 642-648, issn 0006-4971, 7 p.Article